AARHUS, Denmark--(BUSINESS WIRE)--The Department of Molecular Medicine at Aarhus University Hospital is heading a Danish research project on molecular prediction of prostate cancer risk and aggressiveness, where CLC bio will develop the underlying bioinformatics platform for integrated analysis of microarray data and next generation sequencing data. The USD $4M project is funded by the Danish Council for Strategic Research.
